BECTON, DICKINSON AND COMPANY Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax
BECTON, DICKINSON AND COMPANY (BDX) reported Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax of -$15.00 million for the 12-month period ending 2023-09-30, per its 10-K filed 2023-11-21.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax · last filed 2023-11-21
- BECTON, DICKINSON AND COMPANY other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for the quarter ending 2014-09-30 was -$102.00M.
- BECTON, DICKINSON AND COMPANY other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for the quarter ending 2014-06-30 was $0.00.
- BECTON, DICKINSON AND COMPANY other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for fiscal 2023 was -$15.00M, a 131.91% decline from fiscal 2022.
- BECTON, DICKINSON AND COMPANY other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for fiscal 2022 was $47.00M, a 11.90% increase from fiscal 2021.
- BECTON, DICKINSON AND COMPANY other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for fiscal 2021 was $42.00M.
- BECTON, DICKINSON AND COMPANY other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for fiscal 2020 was -$30.00M.
| Period end | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax 3 month | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax 6 month | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax 9 month | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$15.00M 10-K · filed 2023-11-21 | |||
| 2022-09-30 | $47.00M 10-K · filed 2023-11-21 | |||
| 2021-09-30 | $42.00M 10-K · filed 2023-11-21 | |||
| 2020-09-30 | -$30.00M 10-K · filed 2022-11-22 | |||
| 2019-09-30 | -$91.00M 10-K · filed 2021-11-24 | |||
| 2018-09-30 | $19.00M 10-K · filed 2020-11-25 | |||
| 2017-09-30 | $60.00M 10-K · filed 2019-11-27 | |||
| 2016-09-30 | -$79.00M 10-K · filed 2018-11-21 | |||
| 2015-09-30 | -$47.00M 10-K · filed 2017-11-22 | |||
| 2014-09-30 | -$102.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-23 | -$102.00M derived: sum of 2 quarters · filed 2016-11-23 | -$86.00M 10-K · filed 2016-11-23 | |
| 2014-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-04 | $16.00M 10-Q · filed 2014-08-04 | ||
| 2014-03-31 | $16.00M 10-Q · filed 2014-05-05 | |||
| 2013-09-30 | $121.00M 10-K · filed 2015-11-25 | |||
| 2012-09-30 | -$70.00M 8-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |